条件化后的catecholaminergic对抗性未能改变小鼠中的甲基胺敏感度
A S Rauhut1, K Mehta2, N Fedorczak2
1Neuroscience Program, Dickinson College, Carlisle, PA, 17013, United States of America; Psychology Department, Dickinson College, Carlisle, PA, 17013, United States of America.
Pharmacology, biochemistry, and behavior
|November 12, 2025
概括
在小鼠中,单次甲基胺注射会导致持久的行为敏感化和有条件的多动性. 在调节后准儿科胺激素系统并没有影响这些长期寻找药物的行为.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 行为科学 行为科学
背景情况:
- 单次注射敏感化模型研究早期强迫性寻找药物的行为.
- 了解这些行为的持久性和记忆巩固对于成研究至关重要.
研究的目的:
- 为了检查单次甲基胺注射后条件过活和行为敏感化的时间持续性.
- 为了调查catecholaminergic途径在这些药物诱导行为的记忆巩固中的作用.
主要方法:
- 瑞士韦伯斯特雄性小鼠接受了一次甲基胺 (2.0 mg/kg) 或盐水注射.
- 调节后评估了运动运动活动,在不同时间点 (2-28天) 进行了条件过活和敏感化测试.
- 多巴胺D2 (haloperidol) 或β-上腺素 (propranolol) 抗剂在条件化后被使用,以评估记忆巩固效应.
主要成果:
- 在所有测试时间点中,有条件的多动和行为敏感性持续存在.
- 条件化后的哈洛佩里多尔或普拉诺洛尔的使用并没有改变条件化的过敏或行为敏感性.
- 这些发现表明,学科胺体记忆巩固过程不会影响这些行为的诱导.
结论:
- 对单次甲基胺注射的条件和药理反应都是持久的.
- 在记忆巩固过程中准甲基胺系统不会扰乱条件过度活动或行为敏感化的诱导.
- 这些结果为早期成行为的神经生物学基础提供了洞察力.
相关概念视频
01:25Adrenergic Agonists: Indirect-Acting Agents
2.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.5K
01:20Desensitization and Tachyphylaxis
3.0K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.0K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
01:29Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
755
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
755
01:28Adrenergic Agonists: Mixed-Action Agents
1.4K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.4K